|
US2014051592A1
|
|
Protein synthesis modulators
|
|
AU2013200012A1
|
|
Biaryl Heterocyclic Compounds and Methods of Making and Using the Same
|
|
CN103958514A
|
|
Antimicrobial compounds and methods of making and using the same
|
|
AU2012229127A1
|
|
Antimicrobial agents
|
|
JP2011137007A
|
|
Process for synthesis of biaryl oxazolidinone
|
|
BR112012008759A2
|
|
antimicrobial compounds and methods of making and using them
|
|
CA2777741A1
|
|
Antimicrobial compounds and methods of making and using the same
|
|
CN104628729A
|
|
Antimicrobial compounds and methods of making and using the same
|
|
NZ593345A
|
|
Antimicrobial composition comprising a quinolone carboxylic acid derivative and a cyclodextrin
|
|
CN105001207A
|
|
Process for preparing quinolone compounds
|
|
US8374794B1
|
|
Protein synthesis modulators
|
|
WO2008106226A2
|
|
Macrolide compounds and methods of making and using the same
|
|
WO2008085913A1
|
|
Methods for treating, preventing, or reducing the risk of opthalmic, otic, and nasal infections
|
|
WO2007133803A2
|
|
Treatment of mycobacterial infections
|
|
EP1934237A2
|
|
Triazole compounds and methods of making and using the same
|
|
KR20080020669A
|
|
Process for the synthesis of triazoles
|
|
WO2005118610A2
|
|
Macrocyclic compounds and methods of making and using the same
|
|
CN108101948A
|
|
Macrocyclic compound and its making and use method
|
|
EP2716647A2
|
|
Macrocyclic compounds and methods of making and using the same
|
|
US7129259B2
|
|
Halogenated biaryl heterocyclic compounds and methods of making and using the same
|
